25 related articles for article (PubMed ID: 14622150)
1. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor.
Matthes HW; Smadja C; Valverde O; Vonesch JL; Foutz AS; Boudinot E; Denavit-Saubié M; Severini C; Negri L; Roques BP; Maldonado R; Kieffer BL
J Neurosci; 1998 Sep; 18(18):7285-95. PubMed ID: 9736649
[TBL] [Abstract][Full Text] [Related]
2. The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats.
Zamarripa CA; Pareek T; Schrock HM; Prisinzano TE; Blough BE; Sufka KJ; Freeman KB
Psychopharmacology (Berl); 2021 Dec; 238(12):3463-3476. PubMed ID: 34430992
[TBL] [Abstract][Full Text] [Related]
3. Effect of ΔFosB overexpression on opioid and cannabinoid receptor-mediated signaling in the nucleus accumbens.
Sim-Selley LJ; Cassidy MP; Sparta A; Zachariou V; Nestler EJ; Selley DE
Neuropharmacology; 2011 Dec; 61(8):1470-6. PubMed ID: 21907220
[TBL] [Abstract][Full Text] [Related]
4. GTPgammaS incorporation in the rat brain: a study on mu-opioid receptors and CXCR4.
Burbassi S; Aloyo VJ; Simansky KJ; Meucci O
J Neuroimmune Pharmacol; 2008 Mar; 3(1):26-34. PubMed ID: 18247130
[TBL] [Abstract][Full Text] [Related]
5. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene.
Bailey A; Ledent C; Kelly M; Hourani SM; Kitchen I
J Neurosci; 2002 Nov; 22(21):9210-20. PubMed ID: 12417646
[TBL] [Abstract][Full Text] [Related]
6. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain.
Staal RGW; Gandhi A; Zhou H; Cajina M; Jacobsen AM; Hestehave S; Hopper A; Poda S; Chandresana G; Zorn SH; Campbell B; Segerdahl M; Mӧller T; Munro G
Purinergic Signal; 2022 Dec; 18(4):499-514. PubMed ID: 36001278
[TBL] [Abstract][Full Text] [Related]
8. Roles of kappa-opioid receptor agonists in learning and memory impairment in animal models.
Hiramatsu M; Kameyama T
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):595-9. PubMed ID: 9819804
[TBL] [Abstract][Full Text] [Related]
9. U-50,488 and the kappa receptor: a personalized account covering the period 1973 to 1990.
Szmuszkovicz J
Prog Drug Res; 1999; 52():167-95. PubMed ID: 10396128
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
[TBL] [Abstract][Full Text] [Related]
11. Heterologous mu-opioid receptor adaptation by repeated stimulation of kappa-opioid receptor: up-regulation of G-protein activation and antinociception.
Narita M; Khotib J; Suzuki M; Ozaki S; Yajima Y; Suzuki T
J Neurochem; 2003 Jun; 85(5):1171-9. PubMed ID: 12753076
[TBL] [Abstract][Full Text] [Related]
12. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice.
Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF
Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238
[TBL] [Abstract][Full Text] [Related]
13. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
[TBL] [Abstract][Full Text] [Related]
15. Involvement of spinal protein kinase Cgamma in the attenuation of opioid mu-receptor-mediated G-protein activation after chronic intrathecal administration of [D-Ala2,N-MePhe4,Gly-Ol(5)]enkephalin.
Narita M; Mizoguchi H; Narita M; Nagase H; Suzuki T; Tseng LF
J Neurosci; 2001 Jun; 21(11):3715-20. PubMed ID: 11356858
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
